Results 111 to 120 of about 166,202,154 (262)
Out-of-pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross-sectional study. [PDF]
OBJECTIVES: To investigate self-reported out-of-pocket health care expenses, both overall and by cost type, for a large population-based sample of Australians, by cancer status and socio-demographic and medical characteristics.
Karikios, D +7 more
core +1 more source
Orphanet Journal of Rare DiseasesBackground Fabry disease (FD) is a rare inherited X-linked lysosomal disorder caused by the deficiency or dysfunction of the enzyme α-galactosidase.
Ian Keyzor +10 more
doaj +1 more source
Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.Purpose To assess the availability, price transparency, and pricing of platelet‐rich plasma (PRP), bone marrow aspirate concentration, and stem cell injections for knee osteoarthritis (OA) among orthopaedic sports medicine (OSM) practices and alternative clinics in suburban New York and to evaluate the impact of the economic status of a population on ...
Tracy M. Tauro +6 more
wiley +1 more source
Family out-of-pocket health expenses, United States, 1975 [PDF]
Statistics on the annual out-of-pocket health expenses during 1975 of families and unrelated individuals, by type of expense, type of family unit, proportion of family units with no expense, and intervals of expense.
core
National Health Insurance on Household Out-of-pocket Health Expenses in Indonesia [PDF]
BPJS Kesehatan is expected to increase access to fair and high-quality health care for all citizens and provide financial risk protection. Our study aims to examine the impact of BPJS Kesehatan’s implementation as national health insurance (NHI) on ...
Wijayati, Ira Yusnita, Handayani, Dwini
core +1 more source
Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans
Arthritis &Rheumatology, EarlyView.Objective We examine coverage of self‐administered disease‐modifying antirheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022–2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T cell costimulatory modulator, interleukin‐6 (IL ...
Youngmin Kwon +2 more
wiley +1 more source
The health care system reform in China: effects on out-of-pocket expenses and saving. [PDF]
, 2013 This paper aims at evaluating the impact of 1998 Chinese health care reform on out-of-pocket expenditure and on saving. Existing evidence on the results achieved by this reform in terms of reduction of out-of-pocket medical expenditures is still mixed ...
V. Atella +5 more
core
British Educational Research Journal, EarlyView.Abstract The intersection of economic conditions and early years education has long been debated, particularly where financial constraints shape educational practice and professional realities. Türkiye, characterised by high inflation and structural vulnerabilities in purchasing power parity, provides a critical context for examining how economic ...
Ebru Aydın, Şerif Yüksel
wiley +1 more source
Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration
BMEMat, EarlyView.The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang +13 more
wiley +1 more source
Family out-of-pocket health expenses, United States, 1970 [PDF]
Statistics on the annual out-of-pocket health expenses of families and unrelated individuals, by type of expense, type of family unit, proportion of family units with no expense, and intervals of expense.
core